Genomic & Biopharma NewsLawsuit says Novo, OptumRx 'mutually benefited' from rebate scheme, while consumers paid the price
Novo Nordisk is the target, along with pharmacy benefit manager OptumRX, of a new proposed class action lawsuit claiming a conspiracy to raise the price of diabetes medicines so that the drugmaker could pay rebates to the pharmacy benefit manager.
|Fierce Pharma, 2017-05-26 14:12:29|
EpicGenetics looks north to expand landmark fibromyalgia study
The Canadian launch of its fibromyalgia test will help EpicGenetics complete a large-scale trial into the underlying causes of the painful disorder.
|Fierce Biotech, 2017-05-26 13:33:44|
Roche, Boehringer tout new idiopathic pulmonary fibrosis analyses to boost their rival medications
The idiopathic pulmonary fibrosis market-share battle between Roche’s Esbriet and Boehringer Ingelheim’s Ofev hasn’t let up since the FDA green-lighted the medications in October, 2014. And this week, both drugmakers upped the ante with positive new data for their contenders.
|Fierce Pharma, 2017-05-26 13:33:34|
Celebration to Commemorate Ocean Ridge Biosciences' Re-Opening at New Facility
Ocean Ridge Biosciences (ORB), a leader in RNA profiling and biomarker discovery services, will celebrate a grand re-opening at its new location, 394 SW 12th Avenue, Deerfield Beach, Florida. The event will take place on Friday, November 18th, 2016 from 5:00PM to 8:00PM. Please read the PDF for more details
|ORB Company News, 2016-11-14 17:41:06|
Rush Now Enrolling Patients in Phase 2 Trial Testing Opdivo Combo Therapies for Advanced Renal Cell Carcinoma
|Immuno-Oncology News, 2017-05-26 13:33:12|
FiercePharmaAsia—Gardasil’s Chinese approval, Lupin’s financials, CANbridge’s $25M series B
Merck's HPV shot Gardasil is set for a head-to-head competition with GSK's Cervarix in China, Lupin's Q4 sales in North America fell 13%, China’s CANbridge gained a $25M series B to advance immunotherapies, and more.
|Fierce Pharma, 2017-05-26 13:23:33|
ORB relocates to Deerfield Beach and celebrates grand opening of new facility with local researchers
After 8 years of operation in Palm Beach Gardens, Ocean Ridge Biosciences (ORB) has recently relocated to a 5,394 sq. ft. facility in Deerfield Beach, Florida. The new facility provides several improvements which will enable ORB to provide improved and expanded services to academic and corporate clients. These include:
|ORB Company Blog, 2016-11-21 19:26:55|
TSRI scientists discover potential new therapy to stop deadly botulinum neurotoxin
Botulinum neurotoxin is probably best known to Americans as BOTOX, a cosmetic medicine, rather than as a cause of potentially dangerous foodborne illnesses.
|News Medical Life Sciences, 2017-05-26 13:16:25|
Roche helps Senseonics raise $41M to push diabetes device
Senseonics is set to raise $41 million to support the anticipated commercialization of implantable continuous glucose monitoring system Eversense. The fundraising attracted the support of major existing shareholders New Enterprise Associates and Roche.
|Fierce Biotech, 2017-05-26 13:14:45|
Biovica appoints Samuel Rotstein as Scientific Advisor
Dr Rotstein received his Ph.D at Karolinska Institutet and has worked as an oncologist for almost 40 years. He was previously Head of Department at the Oncology Clinic at Danderyd Hospital where he together with his colleagues built and managed a highly-appreciated breast cancer clinic.
|News Medical Life Sciences, 2017-05-26 13:12:00|
Combined use of two existing drugs appears to slow cancer's tendency to spread, study shows
A team led by Johns Hopkins researchers has discovered a biochemical signaling process that causes densely packed cancer cells to break away from a tumor and spread the disease elsewhere in the body.
|News Medical Life Sciences, 2017-05-26 13:04:46|